NCT02027376View on ClinicalTrials.gov

Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Advanced Breast Cancer
Interventions
DRUG

LDE225

DRUG

Docetaxel

Trial Locations (5)

15006

Complejo Hospitalario Universitario A Coruña, A Coruña

28007

Hospital General Universitario Gregorio Marañón, Madrid

28040

Hospital Clínico Universitario San Carlos, Madrid

29010

Hospital Clínico Universitario Virgen de la Victoria, Málaga

41071

Hospital Universitario Virgen del Rocío, Seville

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Spanish Breast Cancer Research Group

OTHER